立体定向放射外科治疗放射诱发性脑膜瘤的结局
单中心回顾1999年8月至2020年10月钴-60立体定向放射外科(SRS)病例,按Cahan标准识别29例患者共86个放射诱发性脑膜瘤(RIM)病灶。中位随访59个月,5年总生存率和无进展生存率分别为96%和68%,1年、3年、5年局部控制率分别为82%、76%、74%,治疗后I-III级毒性发生率为9.0%。
要点
- 复发RIM的3年无进展生存率为45%,低于 upfront 治疗的94%(p<0.005)。
- WHO I级或推测I级RIM的3年无进展生存率为96%,高于WHO II级的20%(p<0.005)。
- 多变量分析中女性与局部控制改善相关(p<0.001),边缘剂量>14 Gy与局部控制变差相关(p<0.001)。
核心结论
- SRS是影像学RIM、WHO I级RIM或 upfront 治疗病灶的安全有效治疗选择,WHO II级和复发病灶疾病进展风险增加。
研究设计与样本
- 单中心回顾性数据库分析,纳入1999年8月至2020年10月钴-60 SRS病例,按Cahan标准识别RIM,共29例患者86个病灶。
主要发现
- SRS后中位随访59个月,处方至50%等剂量线的中位剂量为14 Gy(范围12-20 Gy)。
- 5年总生存率为96%,5年无进展生存率为68%。
- 复发RIM的3年无进展生存率为45%,upfront 治疗为94%(p<0.005)。
- 推测或WHO I级RIM的3年无进展生存率为96%,WHO II级为20%(p<0.005)。
- 按病灶计算,1年、3年、5年局部控制率分别为82%、76%、74%;多变量分析中女性与局部控制改善相关(p<0.001),边缘剂量>14 Gy与局部控制变差相关(p<0.001)。
临床怎么用
- 原文结论认为SRS是影像学RIM、WHO I级RIM或 upfront 治疗病灶的安全有效治疗选择。
- 原文结论指出WHO II级病灶和复发病灶疾病进展风险增加。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Data on the efficacy and safety of stereotactic radiosurgery (SRS) for treatment of radiation-induced meningiomas (RIMs) are limited. METHODS: A single institution database of Cobalt-60 SRS cases from 08/1999 to 10/2020 was reviewed. Radiation-induced meningiomas were identified using Cahan's criteria. Endpoints included overall survival (OS), progression free survival (PFS), local control (LC), treatment failure, and treatment toxicity. Univariate and multivariate analyses were performed using cox proportional hazard models. RESULTS: A total of 29 patients with 86 RIM lesions were identified. Median follow-up after SRS was 59 months. The median dose prescribed to the 50% isodose line was 14 Gy (range 12-20 Gy). The actuarial 5-yr OS and PFS were 96% and 68%, respectively. Patients treated for recurrent RIMs had a significantly lower PFS (45% vs 94% at 3 yr, p < 0.005) than patients treated in the upfront setting. Patients with presumed or WHO grade I RIMs had a significantly greater PFS (3-year PFS 96% vs 20%) than patients with WHO grade II RIMs (p < 0.005). On a per-lesion basis, local control (LC) at 1-, 3-, and 5-yrs was 82%, 76%, 74%, respectively. On multivariate analysis, female gender was associated with improved LC (p < 0.001), while marginal doses > 14 Gy were associated with worse local control (p < 0.001). Grade I-III toxicity following treatment was 9.0%. CONCLUSIONS: Stereotactic radiosurgery is a safe and effective treatment option for radiographic RIMs, WHO grade I RIMs, or lesions treated in the upfront setting. WHO grade II lesions and recurrent lesions are at increased risk for disease progression.
引用
- Razavian NB, Helis CA, Laxton A, et al. Outcomes of radiation-induced meningiomas treated with stereotactic radiosurgery. J Neurooncol. 2022. PMID: 36222952. doi:10.1007/s11060-022-04156-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。